Cargando…

Renal side effects of COVID-19 vaccines in patients with immunoglobulin A nephropathy

Detalles Bibliográficos
Autores principales:	Park, Jae Seok, Lee, Eun Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Nephrology 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816416/ https://www.ncbi.nlm.nih.gov/pubmed/35108771 http://dx.doi.org/10.23876/j.krcp.21.233

Ejemplares similares

COVID-19 Vaccination in Immunoglobulin A Nephropathy
por: Lim, Cynthia Ciwei, et al.
Publicado: (2021)

Side effects of COVID-19 vaccination and breast cancer
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
por: Østergaard, Søren Dinesen, et al.
Publicado: (2021)

Guillain-Barré syndrome after vaccination against COVID-19
por: Chun, June Young, et al.
Publicado: (2022)

Renal outcomes in immunoglobulin A nephropathy following COVID-19 vaccination: a retrospective cohort study
por: Lim, Ru Sin, et al.
Publicado: (2022)

Renal Side Effects of COVID-19 Vaccination
por: Zhang, Junfeng, et al.
Publicado: (2022)

Erratum: Correction of Authors' Name Spelling in the Article “COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology”
por: Park, Jin Kyun, et al.
Publicado: (2021)

Letter to the Editor: Consideration of Neuroimmunological Diseases in Assessments of COVID-19 Vaccination Rates Among Patients With Chronic Medical Conditions
por: Kim, Sohyeon, et al.
Publicado: (2023)

Immunomodulators in COVID-19: Two Sides to Every Coin
por: Snow, Timothy A. C., et al.
Publicado: (2020)

COVID-19 and mental health: the other side of the coin
por: Demartini, Benedetta, et al.
Publicado: (2021)

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Growing risk of aristolochic acid nephropathy in the era of COVID-19 – Correspondence
por: Das, Tuyelee, et al.
Publicado: (2022)

Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy
por: Shen, Yunzhu, et al.
Publicado: (2022)

COVID-19 Vaccine Effectiveness
por: Shader, Richard I.
Publicado: (2021)

Concurrent Drug-Induced Linear Immunoglobulin A Dermatosis and Immunoglobulin A Nephropathy
por: Kim, Ji Seok, et al.
Publicado: (2015)

Remission of Subacute Psychosis in a COVID-19 Patient With an Antineuronal Autoantibody After Treatment With Intravenous Immunoglobulin
por: McAlpine, Lindsay S., et al.
Publicado: (2021)

Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation
por: Moroni, Gabriella, et al.
Publicado: (2019)

Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma
por: Runnstrom, Martin C., et al.
Publicado: (2022)

Autoimmune hepatitis in a patient with immunoglobulin A nephropathy: A case report
por: Jeon, You Hyun, et al.
Publicado: (2020)

High serum and urine neutrophil gelatinaseassociated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy
por: Rhee, Harin, et al.
Publicado: (2015)

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy
por: Kim, Su-Ji, et al.
Publicado: (2012)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccines: effectiveness and number needed to treat
por: Correia, Luis C L, et al.
Publicado: (2021)

Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages
por: Gao, Hui-Xia, et al.
Publicado: (2020)

Response to comment on “New therapeutic agents in diabetic nephropathy”
por: Kim, Yaeni, et al.
Publicado: (2017)

Concurrent Linear Immunoglobulin A Dermatosis, Hashimoto Thyroiditis, and Immunoglobulin A Nephropathy in an Adult
por: Yang, Ji Young, et al.
Publicado: (2017)

Focal segmental glomerulosclerosis following the Pfizer-BioNTech COVID-19 vaccine
por: Lim, Cho A, et al.
Publicado: (2022)

COVID-19 vaccinations in patients with inflammatory bowel disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Clinical and immunological characteristics of vaccinated patients with COVID-19
por: Ping, Yu, et al.
Publicado: (2022)

Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients
por: Papa, Alfredo, et al.
Publicado: (2021)

Efficacy and safety of Telitacicept in patients with IgA nephropathy
por: Liang, Dongrui, et al.
Publicado: (2023)

Booster vaccines for COVID-19 vaccine breakthrough cases?
por: Nixon, Douglas F, et al.
Publicado: (2022)

Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin
por: McAlpine, Lindsay S., et al.
Publicado: (2023)

Corneal Graft Rejection after Vaccination against COVID-19: A Case Report
por: Park, Ji Min, et al.
Publicado: (2023)

Membranous Nephropathy Associated with Tuberculosis
por: Shang, Ming-Hua, et al.
Publicado: (2016)

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
por: Sgalla, Giacomo, et al.
Publicado: (2022)

Serum and urine metabolomic biomarkers for predicting prognosis in patients with immunoglobulin A nephropathy
por: Jeon, You Hyun, et al.
Publicado: (2023)

COVID-19 vaccines: effectiveness and number needed to treat – Authors' reply
por: Olliaro, Piero, et al.
Publicado: (2021)

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
por: Higdon, Melissa M, et al.
Publicado: (2022)

Association between Covid-19 Vaccination and Influenza Vaccination Rates
por: Leuchter, Richard K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hufa1mr9ask4mgcn5sk420u7qj